Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33886101881;101882;101883 chr2:178534959;178534958;178534957chr2:179399686;179399685;179399684
N2AB3224596958;96959;96960 chr2:178534959;178534958;178534957chr2:179399686;179399685;179399684
N2A3131894177;94178;94179 chr2:178534959;178534958;178534957chr2:179399686;179399685;179399684
N2B2482174686;74687;74688 chr2:178534959;178534958;178534957chr2:179399686;179399685;179399684
Novex-12494675061;75062;75063 chr2:178534959;178534958;178534957chr2:179399686;179399685;179399684
Novex-22501375262;75263;75264 chr2:178534959;178534958;178534957chr2:179399686;179399685;179399684
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Kinase-1
  • Domain position: 74
  • Q(SASA): 0.484
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/D rs1171862038 -0.054 None N None 0.227 0.266385636622 gnomAD-4.0.0 1.36932E-06 None None None None N None 0 0 None 0 0 None 0 0 1.7991E-06 0 0
E/Q None None None N None 0.323 0.27479166964 gnomAD-4.0.0 2.40065E-06 None None None None N None 0 0 None 0 0 None 0 0 2.62501E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.523 ambiguous 0.5242 ambiguous -0.518 Destabilizing None None None None N 0.456960622 None None N
E/C 0.98 likely_pathogenic 0.984 pathogenic -0.154 Destabilizing None None None None None None None None N
E/D 0.3384 likely_benign 0.347 ambiguous -0.383 Destabilizing None None None None N 0.376784898 None None N
E/F 0.9805 likely_pathogenic 0.9809 pathogenic -0.376 Destabilizing None None None None None None None None N
E/G 0.4508 ambiguous 0.442 ambiguous -0.739 Destabilizing None None None None N 0.428944515 None None N
E/H 0.8904 likely_pathogenic 0.8807 pathogenic -0.283 Destabilizing None None None None None None None None N
E/I 0.9207 likely_pathogenic 0.9291 pathogenic 0.039 Stabilizing None None None None None None None None N
E/K 0.6046 likely_pathogenic 0.5616 ambiguous 0.008 Stabilizing None None None None N 0.417402157 None None N
E/L 0.8928 likely_pathogenic 0.893 pathogenic 0.039 Stabilizing None None None None None None None None N
E/M 0.905 likely_pathogenic 0.9176 pathogenic 0.201 Stabilizing None None None None None None None None N
E/N 0.6686 likely_pathogenic 0.685 pathogenic -0.21 Destabilizing None None None None None None None None N
E/P 0.944 likely_pathogenic 0.9266 pathogenic -0.127 Destabilizing None None None None None None None None N
E/Q 0.4102 ambiguous 0.3924 ambiguous -0.171 Destabilizing None None None None N 0.437220068 None None N
E/R 0.7134 likely_pathogenic 0.6684 pathogenic 0.236 Stabilizing None None None None None None None None N
E/S 0.5831 likely_pathogenic 0.5878 pathogenic -0.428 Destabilizing None None None None None None None None N
E/T 0.6542 likely_pathogenic 0.6758 pathogenic -0.256 Destabilizing None None None None None None None None N
E/V 0.7821 likely_pathogenic 0.8009 pathogenic -0.127 Destabilizing None None None None N 0.469505845 None None N
E/W 0.9887 likely_pathogenic 0.9893 pathogenic -0.222 Destabilizing None None None None None None None None N
E/Y 0.954 likely_pathogenic 0.9498 pathogenic -0.15 Destabilizing None None None None None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.